1.
Respirol Case Rep
; 12(2): e01298, 2024 Feb.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38379821
RESUMEN
We herein report a case of interstitial lung changes in a patient with prolonged coronavirus disease 2019 (COVID-19) with follicular lymphoma receiving rituximab and bendamustine who recovered after treatment with a combination therapy consisting of corticosteroids and immunosuppressive agents. There is currently no treatment strategy for prolonged pneumonitis following COVID-19, which can be life-threatening for immunocompromised patients. Thus, further investigation is warranted.